NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: VEEA 30.24%
Veea Shares Surge After Launch of TerraFabric Edge Computing Platform
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NYSE: NGNE 47.03%
NYSE: EDSA 47.03%
NYSE: VEEA 47.03%
NYSE: CDIO 47.03%
NYSE: BATL 47.03%
